Researchers at the NIH successfully introduced a light-absorbing protein into mouse retinal cells, enabling them to send signals to the brain and regain some visual function. The study suggests that this approach could be used to treat various forms of retinal degenerative eye diseases.
Treatment improved vision in older children with amblyopia, with 53% of age seven-12 year olds showing significant improvement when treated with glasses and patches. Most children were left with some visual impairment despite treatment.
A comprehensive study found that US Latinos have high rates of diabetic retinopathy, open-angle glaucoma, and cataract, with significant disparities in healthcare access. Researchers emphasize the importance of providing culturally tailored programs to detect and manage eye diseases in this population.
The study found that daily pressure-lowering eye drops reduced the development of primary open-angle glaucoma in African Americans by almost 50%. This suggests that comprehensive dilated eye examinations should be recommended at least once every two years for African Americans over age 40.
The study projects that vision loss from eye diseases will reach 5.5 million Americans by 2020, with age-related macular degeneration, glaucoma, and cataract being the most common causes. Regular comprehensive eye exams are crucial for preventing and/or delaying eye disease in those at higher risk.
Researchers at the NIH's National Eye Institute have developed a new therapy, daclizumab, that controls uveitis inflammation in seven of 10 patients over a four-year period. The therapy is well-tolerated and may allow patients to administer it to themselves at home.
A new study finds that patching the unaffected eye for two hours daily is as effective as patching for six hours in treating moderate amblyopia in children. The results improve visual acuity and reduce social stigma associated with treatment, making it easier for parents to monitor their child's progress.
Researchers found that treating people with early-stage glaucoma immediately can delay disease progression and slow vision loss. The study followed 255 patients with early stage glaucoma in at least one eye, finding that treatment led to a slower rate of disease progression.
A recent study found that pressure-lowering eye drops reduced the development of primary open-angle glaucoma by over 50 percent. The study suggests that treating people with elevated eye pressure may delay or prevent glaucoma, particularly in those at higher risk due to age, ethnicity, or ocular characteristics.
Researchers found that atropine eye drops work as well as patching in treating amblyopia, a condition affecting two to three out of every 100 children. The treatment improved vision in the affected eye, strengthening it and improving overall quality of life.
A nationwide clinical trial found that a dietary supplement of antioxidants and zinc significantly reduces the risk of advanced age-related macular degeneration (AMD) and its associated vision loss. The supplements reduced the risk of AMD progression by 19% in those with intermediate AMD.
Researchers found that survival rates for primary eye cancer treatments are essentially the same, with a five-year survival rate of 82% for both radiation therapy and eye removal. The study's findings expand the capability of doctors to provide accurate diagnoses and state-of-the-art treatments.
Researchers found that controlled amounts of supplemental oxygen do not worsen retinopathy of prematurity in premature infants. However, the study suggests that it may help prevent the disease's progression to severe stages, potentially reducing the need for invasive surgery and long-term side effects.
African Americans with diabetes who receive health education messages are more likely to seek an eye exam, increasing the rates of dilated eye exams. Early detection and treatment can prevent vision loss in people with diabetes, with about 90% preserving their vision.
Researchers found that highly active antiretroviral therapy (HAART) helped patients with CMV retinitis stop taking standard anti-CMV medications without progression. HAART also partially restored the immune system, allowing it to fight other serious infections.